Just another WordPress site
Isis cholesterol drug lowers LDL levels 26th March 2007, By Victoria Harrison Isis Pharmaceuticals has said new results from its monotherapy phase II clinical trial of cholesterol drug showed improvements in LDL cholesterol. Patients with high cholesterol were treated for ten weeks with 400 mg/week of the drug ISIS 301012. In this study, increasing the [...]
Hemochromatosis gene linked to stroke risk Mar 26, 2007 NEW YORK (Reuters Health) – Patients with a specific gene variation for hereditary hemochromatosis, an autosomal recessive disease associated with increased iron accumulation, have more than double the risk of stroke, new research suggests. Hemochromatosis affects how the body metabolizes iron, which results an iron build-up [...]
Pfizer says new studies show higher dose of Lipitor slows atherosclerosis 26 Mar 2007 LONDON (AFX) – Pfizer Inc said results from two new imaging trials show a higher dose of its cholesterol-fighting drug Lipitor stopped the progression of atherosclerosis in patients with coronary heart disease or familial hypercholesterolemia (FH). The results are part of [...]
Crestor Effective at Halting Early Atherosclerosis This press release issued by Eurekalert says that an international study using ultrasound technology has found that the most potent cholesterol-lowering drug is also effective at halting early changes in the blood vessels that can lead to atherosclerosis. Results from the study were reported at the annual meeting of [...]